Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial Meeting Abstract
| Authors: | O'Connor, O. A.; Masszi, T.; Savage, K. J.; Pinter-Brown, L. C.; Foss, F. M.; Popplewell, L.; Cashen, A. F.; Doorduijn, J.; Chawla, S.; Knoblauch, P.; Zinzani, P. L.; Brown, P.; Hess, G.; Van Hoof, A.; Horwitz, S. M.; Shustov, A. R. |
| Abstract Title: | Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602603 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.8507 |
| Notes: | Meeting Abstract: 8507 -- Source: Wos |
